Ignite Creation Date:
2024-06-16 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06435429
Status:
RECRUITING
Last Update Posted:
2024-05-30
First Post:
2024-05-24
Brief Title:
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab Each in Combination With Physicians Choice Chemotherapy for the Treatment of Participants With Metastatic HER2-positive Breast Cancer
Sponsor:
Jazz Pharmaceuticals
Organization:
Jazz Pharmaceuticals
Organization Data
Organization:
Jazz Pharmaceuticals
Class:
INDUSTRY
Study ID:
JZP598-303
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Jazz Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None